The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

BACKGROUND: Effective treatments for COVID-19 are urgently needed, but conducting randomized trials during the pandemic has been challenging. METHODS: The Anti-Coronavirus Therapy (ACT) trials are parallel factorial international trials that aimed to enroll 3500 outpatients and 2500 inpatients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Eikelboom, John, Rangarajan, Sumathy, Jolly, Sanjit S., Belley-Cote, Emilie P., Whitlock, Richard, Beresh, Heather, Lewis, Gayle, Xu, Lizhen, Chan, Noel, Bangdiwala, Shrikant, Diaz, Rafael, Orlandini, Andres, Hassany, Mohamed, Tarhuni, Wadea M., Yusufali, A.M., Sharma, Sanjib Kumar, Kontsevaya, Anna, Lopez-Jaramillo, Patricio, Avezum, Alvaro, Dans, Antonio L., Wasserman, Sean, Felix, Camilo, Kazmi, Khawar, Pais, Prem, Xavier, Denis, Lopes, Renato D., Berwanger, Otavio, Nkeshimana, Menelas, Harper, William, Loeb, Mark, Choudhri, Shurjeel, Farkouh, Michael E., Bosch, Jackie, Anand, Sonia S., Yusuf, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887957/
https://www.ncbi.nlm.nih.gov/pubmed/35252829
http://dx.doi.org/10.1016/j.cjco.2022.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887957/
https://www.ncbi.nlm.nih.gov/pubmed/35252829
http://dx.doi.org/10.1016/j.cjco.2022.02.010

Ejemplares similares